Neurology

The FDA has approved daclizumab (Zinbryta) as a treatment for adults with relapsing forms of multiple sclerosis.

Conditions such as multiple sclerosis, epilepsy and Parkinson’s disease may cause sexual dysfunction.

Fingolimod (Gilenya) has shown inconsistent improvements with disability in multiple sclerosis.

Various benefits associated with fingolimod (Gilenya) observed for relapsing-remitted multiple sclerosis.

Genetic variant in the chromosome 5q11 affects development of multiple sclerosis.

Fasting-like diet shows promise treating autoimmune diseases in small study.

Specific venoms may lead to targeted therapies for conditions such as multiple sclerosis, rheumatoid arthritis, and other inflammatory disorders.

Andrographis paniculata plant reduces fatigue in patients with relapsing-remitting multiple sclerosis.

Yoga and aquatic exercise seen to decrease fatigue, depression, and paresthesia in MS patients.

Study may lead to the development of treatments for disorders with damaged myelin sheath.

Increased gut bacteria linked to inflammation among children with multiple sclerosis.

Patients taking mitoxantrone for multiple sclerosis found to have higher rates of breast and colorectal cancers and leukemia.

Patients administered mitoxantrone for multiple sclerosis carry higher rates of breast and colorectal cancers and leukemia.

Drug produced by medicinal plant Oldenlandia affinis may block the progression of multiple sclerosis.

Difficulties exist between neurologists and insurance companies in regards to multiple sclerosis treatment.

MS patients who use cognitive remediation training program showed improvement in neuropsychological tests.

MS patients have higher rates of many comorbidities except for high cholesterol.

Patients and neurologists have different experiences when providing information and adhering to disease modifying drugs for multiple sclerosis.

Natalizumab has been generally considered among the most effective treatments for relapsing-remitting multiple sclerosis.

Minimizing sedentary behavior offers potential benefits for people with multiple sclerosis.

Top news of the day from across the health care landscape.

Ocrelizumab shows potential treating both relapsing and primary progressive forms of multiple sclerosis.

Ocrelizumab shows potential treating both relapsing and primary progressive forms of multiple sclerosis.

Video game-based cognitive rehabilitation programs show promise in treating multiple sclerosis symptoms.

Zinbryta found to reduce cells that contribute to neurological injury caused by multiple sclerosis.